Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qian Fei

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Blood Science (Baltimore, Md.)|April 11, 2022
Empowering host immunity by kinase-targeting in LSCQian-Fei Wang
Blood|April 4, 2002
CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptorQian-fei Wang, Alan D Friedman
Blood|December 1, 2022
APL: Nemo finds its sea anemoneQian-Fei Wang, Hong-Hu Zhu
Blood Science (Baltimore, Md.)|April 11, 2022
Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencingAiLi Chen, ShaoYan Hu, Qian-Fei Wang
Frontiers of Medicine|November 14, 2024
Immunological face of megakaryocytesYueying Li, Kunying Chen, Qian-Fei Wang
Oncogene|January 23, 2004
C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA bindingRebecca Cleaves, Qian-fei Wang, Alan D Friedman
World Journal of Clinical Cases|October 8, 2021
Gastric cancer with calcifications: A case reportYu-He Lin, Wei Yao, Qian Fei, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Differential principal component analysis of ChIP-seqHongkai Ji, Xia Li, Qian-fei Wang, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|March 1, 2011
[Recent development of targeted drug delivery system]Peng-ju Zhou, Sheng-qi Deng, Qian-fei Gong
Science China. Life Sciences|November 22, 2015
The priming induction regimen of HAG as a low dose chemotherapy strategy in AML clonal evolutionAiLi Chen, JingYi Yang, ShaoYan Hu, et al.
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Blood Science (Baltimore, Md.)|April 11, 2022
Empowering host immunity by kinase-targeting in LSCQian-Fei Wang
Blood|April 4, 2002
CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptorQian-fei Wang, Alan D Friedman
Blood|December 1, 2022
APL: Nemo finds its sea anemoneQian-Fei Wang, Hong-Hu Zhu
Blood Science (Baltimore, Md.)|April 11, 2022
Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencingAiLi Chen, ShaoYan Hu, Qian-Fei Wang
Frontiers of Medicine|November 14, 2024
Immunological face of megakaryocytesYueying Li, Kunying Chen, Qian-Fei Wang
Oncogene|January 23, 2004
C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA bindingRebecca Cleaves, Qian-fei Wang, Alan D Friedman
World Journal of Clinical Cases|October 8, 2021
Gastric cancer with calcifications: A case reportYu-He Lin, Wei Yao, Qian Fei, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Differential principal component analysis of ChIP-seqHongkai Ji, Xia Li, Qian-fei Wang, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|March 1, 2011
[Recent development of targeted drug delivery system]Peng-ju Zhou, Sheng-qi Deng, Qian-fei Gong
Science China. Life Sciences|November 22, 2015
The priming induction regimen of HAG as a low dose chemotherapy strategy in AML clonal evolutionAiLi Chen, JingYi Yang, ShaoYan Hu, et al.
Pageof 14